These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34626549)

  • 1. Transition to endemicity: Understanding COVID-19.
    Antia R; Halloran ME
    Immunity; 2021 Oct; 54(10):2172-2176. PubMed ID: 34626549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characteristics govern the transition of COVID-19 to endemicity.
    Lavine JS; Bjornstad ON; Antia R
    Science; 2021 Feb; 371(6530):741-745. PubMed ID: 33436525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. After the pandemic: perspectives on the future trajectory of COVID-19.
    Telenti A; Arvin A; Corey L; Corti D; Diamond MS; García-Sastre A; Garry RF; Holmes EC; Pang PS; Virgin HW
    Nature; 2021 Aug; 596(7873):495-504. PubMed ID: 34237771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herd immunity to endemic diseases: Historical concepts and implications for public health policy.
    Robertson D; Heriot G; Jamrozik E
    J Eval Clin Pract; 2024 Jun; 30(4):625-631. PubMed ID: 38562003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects.
    Zheng J; Deng Y; Zhao Z; Mao B; Lu M; Lin Y; Huang A
    Cell Mol Immunol; 2022 Feb; 19(2):150-157. PubMed ID: 34645940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herd Immunity: Understanding COVID-19.
    Randolph HE; Barreiro LB
    Immunity; 2020 May; 52(5):737-741. PubMed ID: 32433946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
    Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
    Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-based differences in severity and mortality in COVID-19.
    Alwani M; Yassin A; Al-Zoubi RM; Aboumarzouk OM; Nettleship J; Kelly D; Al-Qudimat AR; Shabsigh R
    Rev Med Virol; 2021 Nov; 31(6):e2223. PubMed ID: 33646622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of Pregnant Women Against COVID-19.
    Abu-Raya B
    Neoreviews; 2021 Sep; 22(9):e570-e573. PubMed ID: 34470758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 pandemic and "survival of the fittest".
    Mukhra R; Krishan K; Kanchan T
    J Infect Dev Ctries; 2021 Oct; 15(10):1384-1387. PubMed ID: 34780359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence between global BCG vaccination and COVID-19 pandemic.
    Islam MZ; Zahan MK; Al-Bari MAA
    J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
    Wratil PR; Schmacke NA; Karakoc B; Dulovic A; Junker D; Becker M; Rothbauer U; Osterman A; Spaeth PM; Ruhle A; Gapp M; Schneider S; Muenchhoff M; Hellmuth JC; Scherer C; Mayerle J; Reincke M; Behr J; Kääb S; Zwissler B; von Bergwelt-Baildon M; Eberle J; Kaderali L; Schneiderhan-Marra N; Hornung V; Keppler OT
    Cell Rep; 2021 Dec; 37(13):110169. PubMed ID: 34932974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations.
    Cava E; Neri B; Carbonelli MG; Riso S; Carbone S
    Clin Nutr; 2021 Apr; 40(4):1637-1643. PubMed ID: 33765600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations.
    Cohen LE; Spiro DJ; Viboud C
    PLoS Pathog; 2022 Jun; 18(6):e1010591. PubMed ID: 35771775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):5-53. PubMed ID: 32744465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology Lessons from the SARS-CoV-2 Pandemic.
    Yokoyama WM; Hogquist KA; O'Shea JJ
    Annu Rev Immunol; 2021 Apr; 39():v-vii. PubMed ID: 33939926
    [No Abstract]   [Full Text] [Related]  

  • 19. The role and delicate balance of Host Immunity in Coronavirus Disease-19.
    Vyas AK; Varma V; Garg G; Gupta P; Trehanpati N
    Iran J Immunol; 2021 Mar; 18(1):1-12. PubMed ID: 33787510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection?
    Hodžić A; de la Fuente J; Cabezas-Cruz A
    ACS Infect Dis; 2020 Dec; 6(12):3104-3108. PubMed ID: 33180463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.